应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ALT Altimmune, Inc.
未开盘 08-12 16:00:00 EDT
2.93
-0.07
-2.33%
盘后
2.95
+0.02
+0.68%
19:59 EDT
最高
3.20
最低
2.92
成交量
604.58万
今开
3.05
昨收
3.00
日振幅
9.33%
总市值
5.68亿
流通市值
5.53亿
总股本
1.94亿
成交额
1,853万
换手率
3.21%
流通股本
1.89亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Altimmune盘前飙升17%，其药物治疗酒精使用障碍中期研究达成主要目标
美股速递 · 07-28
Altimmune盘前飙升17%，其药物治疗酒精使用障碍中期研究达成主要目标
Altimmune旗下Pemvidutide 2.4mg在二期试验中显著减少重度饮酒天数
美股速递 · 07-28
Altimmune旗下Pemvidutide 2.4mg在二期试验中显著减少重度饮酒天数
Altimmune公布Pemvidutide治疗酒精使用障碍的Reclaim 2期临床试验取得积极初步结果
美股速递 · 07-28
Altimmune公布Pemvidutide治疗酒精使用障碍的Reclaim 2期临床试验取得积极初步结果
RootData：ALT 将于一周后解锁价值约 157 万美元的代币
链捕手 · 07-19
RootData：ALT 将于一周后解锁价值约 157 万美元的代币
RootData：ALT 将于一周后解锁价值约 172 万美元的代币
链捕手 · 06-19
RootData：ALT 将于一周后解锁价值约 172 万美元的代币
勃林格殷格翰：同步试验中，Survodutide组84.2%患者肝脂肪减少至少30%，显著优于安慰剂组24.3%
美股速递 · 06-08
勃林格殷格翰：同步试验中，Survodutide组84.2%患者肝脂肪减少至少30%，显著优于安慰剂组24.3%
勃林格殷格翰Survodutide药物显示内脏脂肪减少34%、肝脏脂肪减少63%，并最大限度减少瘦体重流失
美股速递 · 06-08
勃林格殷格翰Survodutide药物显示内脏脂肪减少34%、肝脏脂肪减少63%，并最大限度减少瘦体重流失
RootData：ALT 将于一周后解锁价值约 165 万美元的代币
链捕手 · 05-19
RootData：ALT 将于一周后解锁价值约 165 万美元的代币
Altimmune拟将净收益投入MASH三期临床试验，预计下半年启动
美股速递 · 04-27
Altimmune拟将净收益投入MASH三期临床试验，预计下半年启动
RootData：ALT 将于一周后解锁价值约 177 万美元的代币
链捕手 · 04-19
RootData：ALT 将于一周后解锁价值约 177 万美元的代币
币安将下架 ALT/BNB、ARB/TUSD 等现货交易对
链捕手 · 03-31
币安将下架 ALT/BNB、ARB/TUSD 等现货交易对
RootData：ALT 将于一周后解锁价值约 185 万美元的代币
链捕手 · 03-19
RootData：ALT 将于一周后解锁价值约 185 万美元的代币
RootData：ALT 将于一周后解锁价值约 201 万美元的代币
链捕手 · 02-19
RootData：ALT 将于一周后解锁价值约 201 万美元的代币
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
市场透视 · 2025-03-11
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
Altimmune, Inc.2024财年实现净利润-95.06百万美元，同比减少7.47%
市场透视 · 2025-03-08
Altimmune, Inc.2024财年实现净利润-95.06百万美元，同比减少7.47%
Altimmune, Inc.盘中异动 股价大跌5.07%
市场透视 · 2025-03-07
Altimmune, Inc.盘中异动 股价大跌5.07%
HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
金融界 · 2025-03-04
HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
Altimmune, Inc.盘中异动 股价大跌5.04%
市场透视 · 2025-03-03
Altimmune, Inc.盘中异动 股价大跌5.04%
Altimmune, Inc.盘中异动 早盘股价大涨6.06%
市场透视 · 2025-02-27
Altimmune, Inc.盘中异动 早盘股价大涨6.06%
Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万
财报速递 · 2025-02-27
Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万
加载更多
公司概况
公司名称：
Altimmune, Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide（原名ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎（“NASH”）。
发行价格：
--
{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":2.93,"timestamp":1786564800000,"preClose":3,"halted":0,"volume":6045805,"hourTrading":{"tag":"盘后","latestPrice":2.9499,"preClose":2.93,"latestTime":"19:59 EDT","volume":94336,"amount":278294.1271,"timestamp":1786579199066,"change":0.0199,"changeRate":0.006792,"amplitude":0.017065},"delay":0,"changeRate":-0.02333333333333328,"floatShares":188595244,"shares":194000000,"eps":-0.90779,"marketStatus":"未开盘","change":-0.07,"latestTime":"08-12 16:00:00 EDT","open":3.05,"high":3.2,"low":2.92,"amount":18534372.2784315,"amplitude":0.093333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.90779,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786608000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3,"preHourTrading":{"tag":"盘前","latestPrice":3.05,"preClose":3,"latestTime":"09:28 EDT","volume":101529,"amount":312538.2233292,"timestamp":1786541322279,"change":0.05,"changeRate":0.016667,"amplitude":0.04},"postHourTrading":{"tag":"盘后","latestPrice":2.9499,"preClose":2.93,"latestTime":"19:59 EDT","volume":94336,"amount":278294.1271,"timestamp":1786579199066,"change":0.0199,"changeRate":0.006792,"amplitude":0.017065},"volumeRatio":1.471542,"impliedVol":0.5354,"impliedVolPercentile":0.0757},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"1132863801","title":"Altimmune盘前飙升17%，其药物治疗酒精使用障碍中期研究达成主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1132863801","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132863801?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:13","pubTimestamp":1785237189,"startTime":"0","endTime":"0","summary":"Altimmune（ALT）盘前交易时段股价大幅上涨17%。这一强劲表现源于公司公布了一项积极进展：其在研药物针对酒精使用障碍的中期研究，成功达到了主要终点目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170025455","title":"Altimmune旗下Pemvidutide 2.4mg在二期试验中显著减少重度饮酒天数","url":"https://stock-news.laohu8.com/highlight/detail?id=1170025455","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170025455?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:06","pubTimestamp":1785236798,"startTime":"0","endTime":"0","summary":"Altimmune, Inc.宣布，其研发的Pemvidutide（2.4毫克剂量）在二期临床试验中取得重大突破。数据显示，该药物能够显著降低受试者的重度饮酒天数。这一结果，为酒精使用障碍的治疗领域带来了新的希望。Pemvidutide作为一种创新疗法，其潜力正在被逐步验证。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1878469433.USD","ALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199342012","title":"Altimmune公布Pemvidutide治疗酒精使用障碍的Reclaim 2期临床试验取得积极初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1199342012","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199342012?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:03","pubTimestamp":1785236590,"startTime":"0","endTime":"0","summary":"Altimmune宣布，其Pemvidutide药物在针对酒精使用障碍（Alcohol Use Disorder）的Reclaim 2期临床试验中，获得了令人振奋的初步顶线数据。这些积极结果表明，该疗法展现出显著的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALT","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255112","title":"RootData：ALT 将于一周后解锁价值约 157 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255112","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652255112?lang=zh_cn&edition=full","pubTime":"2026-07-19 11:00","pubTimestamp":1784430003,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 07 月 26 日 8 时解锁约 24659 万枚代币，价值约 157 万美元。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2277152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644887058","title":"RootData：ALT 将于一周后解锁价值约 172 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2644887058","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644887058?lang=zh_cn&edition=full","pubTime":"2026-06-19 11:00","pubTimestamp":1781838005,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 06 月 26 日 8 时解锁约 24659 万枚代币，价值约 172 万美元。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2272359","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","BK4139","BK4599","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153909378","title":"勃林格殷格翰：同步试验中，Survodutide组84.2%患者肝脂肪减少至少30%，显著优于安慰剂组24.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153909378","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153909378?lang=zh_cn&edition=full","pubTime":"2026-06-08 02:31","pubTimestamp":1780857104,"startTime":"0","endTime":"0","summary":"在同步进行的代谢功能障碍相关脂肪性肝病临床试验中，勃林格殷格翰公司宣布了其药物Survodutide的积极数据。结果显示，接受Survodutide治疗的患者中，有高达84.2%的人实现了肝脏脂肪含量减少至少30%的目标。这一疗效数据与安慰剂组形成了鲜明对比——后者仅有24.3%的患者达到相同标准。\n该数据凸显了Survodutide在减少肝脏脂肪堆积方面的显著潜力，为治疗这一日益普遍的肝脏疾病带来了新的希望。随着非酒精性脂肪性肝病领域竞争加剧，包括礼来在内的其他制药巨头也在此赛道积极布局，此次积极结果可能进一步重塑市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","IE00BFTCPJ56.SGD","LU0323591593.USD","LU1232071149.USD","LU0320765059.SGD","LU1064131342.USD","LU1069344957.HKD","LU2063271972.USD","IE00B1XK9C88.USD","LU2089283258.USD","LU2552382215.SGD","LU1868836914.USD","LU2106854487.HKD","LU2028103732.USD","LU2271345857.HKD","LU1629891620.HKD","SG9999014914.USD","LU2756315664.SGD","IE00BN29S564.USD","IE00BKDWB100.SGD","LU0786609619.USD","LU2023251221.USD","LU2237443382.USD","LU2361044949.HKD","LU0417517546.SGD","LU1989771016.USD","LU1127390331.HKD","LU0225283273.USD","LU1720051108.HKD","LU0640476718.USD","IE00BJJMRX11.SGD","LU1291159041.SGD","LU0210536198.USD","BK4139","IE00BJJMRY28.SGD","LU0203202063.USD","LU0109391861.USD","IE0005OL40V9.USD","LU1023059063.AUD","LU0683600562.USD","LU2491050071.SGD","LU2237443895.HKD","LU2264538146.SGD","LU2491050154.USD","LU1035775433.USD","ELIS","IE0004445239.USD","LU1974910355.USD","LU1267930730.SGD","LU0882574139.USD","LU2602419157.SGD","GB00BDT5M118.USD","BK4534","LU2168563687.JPY","LU0158827781.USD","SGXZ81514606.USD","SGXZ51526630.SGD","IE00B4R5TH58.HKD","LU0094547139.USD","SG9999014880.SGD","LU0943347566.SGD","LU1712237335.SGD","LU2237443622.USD","LLYZ","LU0061475181.USD","LU0133085943.USD","LU1548497426.USD","LU0256863811.USD","LU0289739699.SGD","SG9999001176.USD","LU1983299246.USD","LU0823434583.USD","LLII","LU1551013342.USD","LU0158827948.USD","LU2237443978.SGD","SG9999017495.SGD","LU2468319806.SGD","BK4533","IE00BJLML261.HKD","LU2361044865.SGD","LU1988902786.USD","LU2417539215.USD","LU2746668974.SGD","SG9999014898.SGD","SG9999015986.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0689472784.USD","IE00BFSS8Q28.SGD","LU0316494557.USD","LU0353189763.USD","LU0106261372.USD","LU0456855351.SGD","LU0471298777.SGD","LU1280957306.USD","LU2456880835.USD","IE00BKPKM429.USD","LU0823416689.USD","LU2491049909.HKD","LU0006306889.USD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU2357305700.SGD","LU0787776722.HKD","LU0672654240.SGD","LU2471134952.CNY","LU2462157665.USD","LLY","LU0820562030.AUD","LU1868837136.USD","LU0096364046.USD","LU2211815571.USD","LU0964807845.USD","LU2168564495.EUR","LU1878469433.USD","SG9999018857.SGD","LU1323610961.USD","LU2213496289.HKD","LU0353189680.USD","LU2471134879.HKD","LU0820561909.HKD","LU1804176565.USD","LU1720051017.SGD","SG9999015978.USD","LU2237443549.SGD","SGXZ99366536.SGD","IE00B2B36J28.USD","LU2023250330.USD","IE00BWXC8680.SGD","LU1057294990.SGD","LU1366192091.USD","LU2896262040.SGD","LU2237438978.USD","SG9999015952.SGD","LU0079474960.USD","LU0114720955.EUR","LU1917777945.USD","LU2471134796.USD","LU1061106388.HKD","LU2265009873.SGD","BK4588","LU0708995401.HKD","LU0234572021.USD","LU2324357040.USD","LU1093756325.SGD","LU2471134523.USD","LU2168564149.EUR","BK4007","LU1868836757.USD","SG9999001176.SGD","LU0203201768.USD","LU1623119135.USD","LU2461242641.AUD","SG9999013999.USD","IE00B775H168.HKD","LU0466842654.USD","IE00BK4W5L77.USD","IE00BFSS7M15.SGD","LU2168564222.USD","LU0266013472.USD","LU2089984988.USD","BK4516","IE00BK4W5M84.HKD","LU1868837300.USD","IE0004445015.USD","LU0198837287.USD","LU0820561818.USD","LU2360106947.USD","LU2552382058.USD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","BK4585","LU2087625088.SGD","LU2750360997.AUD","IE00B4JS1V06.HKD","SGXZ57979304.SGD","LU0058720904.USD","LLYX","LU0256863902.USD","LU0320765992.SGD","LU2750360641.GBP","LU2746668461.USD","LU2756315318.SGD","LU2361045086.USD","LU0823434740.USD","LU2237443465.HKD","BK4581","LU2552382132.HKD","ALT","LU2108987350.USD","LU2112291526.USD","SG9999018865.SGD","LU2023250504.SGD","SGXZ31699556.SGD","LU0097036916.USD","LU0238689110.USD","LU0354030438.USD","LU0432979614.USD","LU0471298694.HKD","IE0009355771.USD","IE00B1BXHZ80.USD","LU0889565916.HKD","LU1145028129.USD","LU2236285917.USD","LU1551013425.SGD","LU2168564065.EUR","LU0109394709.USD","LU1814569148.SGD","LU0354030511.USD","LU1868836591.USD","ELIL","LU1093756168.USD","LU2111349929.HKD","LU0122379950.USD","SG9999015945.SGD","LU0385154629.USD","SG9999014906.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175987912","title":"勃林格殷格翰Survodutide药物显示内脏脂肪减少34%、肝脏脂肪减少63%，并最大限度减少瘦体重流失","url":"https://stock-news.laohu8.com/highlight/detail?id=1175987912","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175987912?lang=zh_cn&edition=full","pubTime":"2026-06-08 02:30","pubTimestamp":1780857032,"startTime":"0","endTime":"0","summary":"勃林格殷格翰公布的数据显示，其药物Survodutide在临床试验中取得了显著效果，实现了内脏脂肪减少34%和肝脏脂肪减少63%，同时有效控制了瘦体重的流失。这一结果凸显了该药物在治疗与肥胖相关代谢疾病方面的潜力，可能为患者提供一种新的有效治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1623119135.USD","IE00BJT1NW94.SGD","LU0353189763.USD","IE00BFTCPJ56.SGD","LU0096364046.USD","LU1366192091.USD","LU2602419157.SGD","LLY","LU1917777945.USD","SGXZ99366536.SGD","LU0456855351.SGD","ELIL","LU2023250504.SGD","IE00B1BXHZ80.USD","LU0133085943.USD","LU2236285917.USD","LU0238689110.USD","LU2361045086.USD","LU0289739699.SGD","LU1551013342.USD","LU1069344957.HKD","LU0109391861.USD","LU2237443549.SGD","LU1868837300.USD","LU2237443622.USD","LU0061475181.USD","LU1291159041.SGD","LU1551013425.SGD","LU1974910355.USD","LU1280957306.USD","SG9999001176.SGD","LU2211815571.USD","LU1023059063.AUD","LU0889565916.HKD","LU1868836591.USD","LU1061106388.HKD","SGXZ51526630.SGD","LU2264538146.SGD","LU0266013472.USD","LU1629891620.HKD","LU2087625088.SGD","LU0708995401.HKD","LU2023251221.USD","LU2111349929.HKD","LU2168564065.EUR","LU2361044949.HKD","LU0058720904.USD","LU2089984988.USD","LU1804176565.USD","LU2468319806.SGD","IE0004445015.USD","IE00B2B36J28.USD","LU1988902786.USD","IE00B7KXQ091.USD","IE00BN29S564.USD","LU2106854487.HKD","SG9999001176.USD","IE00B4R5TH58.HKD","SG9999015986.USD","LU2461242641.AUD","LU1814569148.SGD","LU2471134879.HKD","LU0320765059.SGD","LU2462157665.USD","LU0122379950.USD","LU0109394709.USD","LU0354030438.USD","LU2357305700.SGD","LU2360106947.USD","LU0203201768.USD","IE0002141913.USD","LU0097036916.USD","LU0234572021.USD","LU2552382058.USD","SG9999013999.USD","IE00B775H168.HKD","IE00BKDWB100.SGD","LU0198837287.USD","LU0471298777.SGD","LU1064131342.USD","BK4516","LU0353189680.USD","LU2063271972.USD","LU2417539215.USD","LU0256863811.USD","SG9999017495.SGD","BK4581","SG9999018857.SGD","IE00BFSS8Q28.SGD","LU2471134523.USD","IE00BK4W5L77.USD","LU0323591593.USD","BK4139","LU0471298694.HKD","LU2237443978.SGD","IE0009355771.USD","LU0640476718.USD","LU2112291526.USD","LU1720051108.HKD","LU1720051017.SGD","LU0225283273.USD","ELIS","LU0417517546.SGD","LU2108987350.USD","LU0786609619.USD","IE00B1XK9C88.USD","LU0114720955.EUR","LLYX","SG9999014914.USD","LU2023250330.USD","LLYZ","IE0001KFT4U8.USD","BK4588","LU2552382132.HKD","LU0882574139.USD","LU1323610961.USD","LU2756315664.SGD","LU2168564495.EUR","LU2324357040.USD","LU1983299246.USD","LU0094547139.USD","BK4007","LU0964807845.USD","IE0005OL40V9.USD","LU2746668974.SGD","SG9999014898.SGD","LU0820561818.USD","LU0203202063.USD","IE00BFSS7M15.SGD","SG9999014906.USD","LU2237443895.HKD","SG9999015978.USD","LU2237443382.USD","ALT","LU0823434583.USD","LU1035775433.USD","IE0004445239.USD","LU0943347566.SGD","LU2361044865.SGD","LU0006306889.USD","LU0316494557.USD","LU1868837136.USD","LU1989771016.USD","SGXZ57979304.SGD","LU2237443465.HKD","LU2491049909.HKD","LU0320765992.SGD","LU1093756325.SGD","IE00B4JS1V06.HKD","LU0787776722.HKD","IE00BKPKM429.USD","BK4599","LU0820562030.AUD","LU0158827781.USD","SG9999014880.SGD","LU2168563687.JPY","LU2089283258.USD","LU2168564222.USD","IE00BJJMRX11.SGD","LLII","LU0823416689.USD","LU0882574055.USD","LU0823434740.USD","LU2028103732.USD","LU2213496289.HKD","LU2471134952.CNY","LU0354030511.USD","IE00BWXC8680.SGD","LU0079474960.USD","BK4585","IE00BJJMRZ35.SGD","LU2896262040.SGD","BK4534","LU2491050154.USD","LU0672654240.SGD","LU1232071149.USD","LU2750360641.GBP","LU1145028129.USD","LU0432979614.USD","LU1868836757.USD","LU2750360997.AUD","LU1267930730.SGD","LU2237438978.USD","LU0210536198.USD","IE00BJLML261.HKD","LU0466842654.USD","IE00BK4W5M84.HKD","LU0683600562.USD","LU0385154629.USD","LU2271345857.HKD","LU1868836914.USD","LU2456880835.USD","LU1712237335.SGD","LU2471134796.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU0820561909.HKD","LU2491050071.SGD","SG9999015952.SGD","LU1548497426.USD","LU1878469433.USD","BK4533","LU1127390331.HKD","LU2746668461.USD","LU0158827948.USD","SGXZ31699556.SGD","LU2756315318.SGD","SG9999018865.SGD","LU0689472784.USD","LU0256863902.USD","LU2089284900.SGD","LU2168564149.EUR","LU2265009873.SGD","SG9999015945.SGD","GB00BDT5M118.USD","LU1057294990.SGD","LU0106261372.USD","LU1093756168.USD","LU2552382215.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636889164","title":"RootData：ALT 将于一周后解锁价值约 165 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2636889164","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636889164?lang=zh_cn&edition=full","pubTime":"2026-05-19 11:00","pubTimestamp":1779159604,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 05 月 26 日 8 时解锁约 24659 万枚代币，价值约 165 万美元。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2265686","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125912412","title":"Altimmune拟将净收益投入MASH三期临床试验，预计下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1125912412","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125912412?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:06","pubTimestamp":1777287994,"startTime":"0","endTime":"0","summary":"生物制药公司Altimmune宣布，计划将此次融资所得净收益专项用于支持其针对代谢相关脂肪性肝炎（MASH）的即将开展的三期临床试验。根据公司最新规划，该项关键性三期试验预计将于今年下半年正式启动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628769434","title":"RootData：ALT 将于一周后解锁价值约 177 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2628769434","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2628769434?lang=zh_cn&edition=full","pubTime":"2026-04-19 17:00","pubTimestamp":1776589203,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 04 月 26 日 8 时解锁约 24659 万枚代币，价值约 177 万美元。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2259589","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623730957","title":"币安将下架 ALT/BNB、ARB/TUSD 等现货交易对","url":"https://stock-news.laohu8.com/highlight/detail?id=2623730957","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623730957?lang=zh_cn&edition=full","pubTime":"2026-03-31 15:31","pubTimestamp":1774942262,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，币安将于 2026 年 4 月 2 日 11:00 下架以下现货交易对：ALT/BNB、ARB/TUSD、BNB/ARS、GALA/ETH、INJ/BNB、SOLV/FDUSD 和 XRP/TUSD。用户仍可在其他交易对上交易相应的基础资产和报价资产。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2255759","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARB","ALT","LU1878469433.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620621881","title":"RootData：ALT 将于一周后解锁价值约 185 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2620621881","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2620621881?lang=zh_cn&edition=full","pubTime":"2026-03-19 11:00","pubTimestamp":1773889205,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 03 月 26 日 8 时解锁约 24659 万枚代币，价值约 185 万美元。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2252988","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4139","ALT","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612271476","title":"RootData：ALT 将于一周后解锁价值约 201 万美元的代币","url":"https://stock-news.laohu8.com/highlight/detail?id=2612271476","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2612271476?lang=zh_cn&edition=full","pubTime":"2026-02-19 11:00","pubTimestamp":1771470005,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据Web3资产数据平台 RootData 代币解锁数据，AltLayer（ALT）将于北京时间 02 月 26 日 8 时解锁约 24659 万枚代币，价值约 201 万美元。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2246679","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518682201","title":"Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518682201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:21","pubTimestamp":1741630882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时21分，Altimmune, Inc.股票出现波动，股价大幅跳水5.12%。截至发稿，该股报5.29美元/股，成交量148.018万股，换手率1.92%，振幅4.90%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5934.70%、3845.43%、1003.65%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517430971","title":"Altimmune, Inc.2024财年实现净利润-95.06百万美元，同比减少7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517430971?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日，Altimmune, Inc.公布财报，公告显示公司2024财年净利润为-95.06百万美元，同比减少7.47%；其中营业收入为20000.00美元，同比减少95.31%，每股基本收益为-1.34美元。从资产负债表来看，Altimmune, Inc.总负债15.80百万美元，其中短期债务279000.00美元，资产负债比为0.09，流动比率为0.14。机构评级：截至2025年3月8日，当前有8家机构对Altimmune, Inc.目标价做出预测，其中目标均价为22.38美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517319420","title":"Altimmune, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517319420?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:05","pubTimestamp":1741287928,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时05分，Altimmune, Inc.股票出现波动，股价大幅下挫5.07%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为4920.76%、3757.89%、255.79%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为125.28%、122.63%、71.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516651619","title":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516651619?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:55","pubTimestamp":1741024555,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Altimmune(ALT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04015548498807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516580806","title":"Altimmune, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516580806?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017238,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分，Altimmune, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报6.32美元/股，成交量54.6719万股，换手率0.77%，振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2916.94%、141.90%、133.69%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385796","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514385796?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Altimmune, Inc.股票出现波动，股价快速上涨6.06%。截至发稿，该股报6.30美元/股，成交量22.7561万股，换手率0.32%，振幅4.55%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为430.02%、92.85%、67.12%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.42%、15.14%、14.83%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127825329","title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1127825329","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127825329?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:07","pubTimestamp":1740658067,"startTime":"0","endTime":"0","summary":"Altimmune报告2024年第四季度每股亏损为$，符合分析师的共识预期。公司本季度报告收入为$5.00千，与去年同期的$37.00千相比下降了86.49%。以上内容来自Benzinga Earnings专栏，原文如下：Altimmune reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $ per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 86.49 percent decrease over sales of $37.00 thousand the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33)，符合预期，收入同比下降至$5.00千，现金及短期投资$131.9百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0201},{"period":"3month","weight":0.0034},{"period":"6month","weight":-0.3532},{"period":"1year","weight":-0.1906},{"period":"ytd","weight":-0.1884}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0311},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1331},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide（原名ALT-801）是一种GLP-1/胰高血糖素双受体激动剂，正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎（“MASH”），以前称为非酒精性脂肪性肝炎（“NASH”）。","yearOnYearQuotes":[{"month":1,"riseRate":0.421053,"avgChangeRate":0.021325},{"month":2,"riseRate":0.368421,"avgChangeRate":-0.012068},{"month":3,"riseRate":0.368421,"avgChangeRate":-0.06468},{"month":4,"riseRate":0.368421,"avgChangeRate":-0.055226},{"month":5,"riseRate":0.526316,"avgChangeRate":0.069937},{"month":6,"riseRate":0.368421,"avgChangeRate":-0.000321},{"month":7,"riseRate":0.368421,"avgChangeRate":0.036187},{"month":8,"riseRate":0.473684,"avgChangeRate":0.100299},{"month":9,"riseRate":0.210526,"avgChangeRate":-0.115822},{"month":10,"riseRate":0.263158,"avgChangeRate":0.032599},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.007448},{"month":12,"riseRate":0.526316,"avgChangeRate":0.184275}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}